Tuesday, Apr 23, 2024 · SEC filings

What the smart money revealed on Apr 23

Real insider buys21insiders · $17.6M
Real insider sales33insiders · $20.6M
Fund 13Fs filed—not loaded for this day
Activist 13Ds filed—not loaded for this day

355 insider filings came in. We hid 40 planned (10b5-1) sellers and 246 people whose filings were routine, like grants and tax withholding.

group

3 insiders at Biohaven (BHVN) bought $15M of stock

Roles: CEO, Director. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Apr 22
$15M
trending_up

KKR Private Equity Conglomerate Director Thomas Naratil bought $2M

76,997 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Apr 19
$2M
trending_up

Vivakor (VIVK) CEO James Ballengee bought $223K

168,000 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Apr 19–22
$223K
trending_up

Lovesac (LOVE) EVP and CFO Keith Siegner bought $99.9K

4,800 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Apr 19
$99.9K
trending_up

Mexico Fund (MXF) Director Richard Vaughan bought $70.8K

4,000 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Apr 22
$70.8K
trending_down

Delta Air Lines (DAL) President Glen Hauenstein sold $4.91M

Not marked as a planned 10b5-1 sale. Sold 31% of the shares they held directly. Still holds 217,584 shares.

Real sale Form 4 Sold 31% of stake Traded Apr 22
$4.91M
trending_down

Salesforce (CRM) Pres. and Chief Product Officer R. David Schmaier sold $2.26M

Not marked as a planned 10b5-1 sale. Sold 31% of the shares they held directly. Still holds 18,787 shares.

Real sale Form 4 Sold 31% of stake Traded Apr 23
$2.26M
trending_down

Argan (AGX) Director W Mitchell sold $154K

Not marked as a planned 10b5-1 sale. Sold 50% of the shares they held directly. Still holds 2,500 shares.

Real sale Form 4 Sold 50% of stake Traded Apr 19
$154K
Show 14 more real buys
Show 30 more real sales
BNY Bank of New York Mellon · SEVP and General Counsel J. Kevin McCarthy · Traded Apr 19
$2.25M
TEAM Atlassian · Co-CEO Michael Cannon-Brookes · Traded Apr 22
$1.59M
TEAM Atlassian · Co-CEO Scott Farquhar · Traded Apr 22
$1.59M
CRM Salesforce · Co-Founder and CTO Parker Harris · Traded Apr 23
$1.13M
CRM Salesforce · President and CFO Amy Weaver · Traded Apr 23
$1.12M
SCHW Charles Schwab · Director Stephen Ellis · Traded Apr 19
$1.08M
STZ Constellation Brands · President and CEO William Newlands · Traded Apr 19
$1.06M
SIG Signet Jewelers · Director H. Todd Stitzer · Traded Apr 22
$1M
CRM Salesforce · EVP and Chief Accounting Officer Sundeep Reddy · Traded Apr 23
$662K
GBX Greenbrier Companies · CEO and President Lorie Tekorius · Traded Apr 22
$501K
GBX Greenbrier Companies · SVP and President William Glenn · Traded Apr 19
$301K
FITB Fifth Third Bancorp · EVP Kristine Garrett · Traded Apr 23
$274K
CRTO Criteo S.A. · CFO Sarah Glickman · Traded Apr 23
$195K
PG Procter & Gamble · CEO - Beauty R. Alexandra Keith · Traded Apr 22
$136K
MKC McCormick · Chief Growth Officer Katherine Jenkins · Traded Apr 22
$128K
CRNC Cerence · CEO Stefan Ortmanns · Traded Apr 22
$108K
DHI D.R. Horton · Director Barbara Allen · Traded Apr 23
$53.9K
FNKO Funko · Chief Commercial Officer Andrew Oddie · Traded Apr 22
$14.6K
INDI indie Semiconductor · COO Michael Wittmann · Traded Apr 22
$9.51K
KPTI Karyopharm Therapeutics · EVP and Chief Medical Officer Reshma Rangwala · Traded Apr 22
$7.94K
KLRS Allovir · CEO Diana Brainard · Traded Apr 19
$7.2K
SEAT Vivid Seats · Chief Strategy Officer Riva Bakal · Traded Apr 22
$6.7K
QTTB Q32 Bio · Officer Paul Alloway · Traded Mar 25 · Filed late
$6.49K
CDLX Cardlytics · Chief Legal and Privacy Officer Nicholas Lynton · Traded Apr 23
$3.52K
SEAT Vivid Seats · Chief Accounting Officer Edward Pickus · Traded Apr 22
$3.17K
KLRS Allovir · Officer Vikas Sinha · Traded Apr 19–22
$2.53K
QTTB Q32 Bio · Officer Charles Michaud Jr. · Traded Mar 25 · Filed late
$1.81K
FNKO Funko · Acting CFO Yves Le Pendeven · Traded Apr 22
$1.39K
KLRS Allovir · General Counsel Edward Miller · Traded Apr 19–22
$1.04K
KLRS Allovir · Chief Accounting Officer Brett Hagen · Traded Apr 19–22
$715

13F season

Holdings as of Mar 31, 2024 are due May 15

50 funds have filed so far. 49 filed for the quarter before.

Biggest real insider buys, Apr 17–23

Open-market buys by officers and directors, filed in the 7 days up to Apr 23.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist